HRAS and glioma: In addition, a significant downregulation of HRAS, but no change in the Spry2 transcript level was observed for MAPK signaling pathway, in accordance with a previous report that miR-21 suppresses Spry2 expression at the protein level and thereby disrupts the negative feedback circuit of Ras/MAPK signaling in glioma [42].